China · Delayed Price · Currency is CNY Huadong Medicine Company Description
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally.
It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments.
The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, and medical apparatus and equipment.
It also manufactures and sells antibiotics, Chinese patent medicines, synthetic drugs, and genetic engineering drugs; and engages in pharmaceutical logistics and industrial microbiology activities.
In addition, the company provides business, leasing, and warehousing services. The company has a strategic cooperation agreement with SynerK PharmaTech (Suzhou) Co., Ltd. to develop the small nucleic acid (siRNA) drug SNK-2726, an angiotensinogen (AGT) for the treatment of hypertension.
Huadong Medicine Co., Ltd was incorporated in 1993 and is headquartered in Hangzhou, China.
| Country | China |
| Founded | 1993 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 18,265 |
| CEO | Liang Lv |
Contact Details
Address: No. 866 Moganshan Road Hangzhou, Zhejiang Province 310011 China | |
| Phone | 86 571 8990 3388 |
| Website | eastchinapharm.com |
Stock Details
| Ticker Symbol | 000963 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE0000011S1 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Liang Lv | Chairman and GM |
| Renbo Qiu | Chief Financial Officer and Head of Accounting Department |
| Bo Chen | Secretary of the Board |